Please login to the form below

Not currently logged in
Email:
Password:

Cerenis appoints Dr John Paolini as chief medical officer

He will be responsible for the strategic planning and execution of the biopharmaceutical company's clinical trials

Dr John Paolini has joined biopharmaceutical company Cerenis as chief medical officer.

Dr Paolini comes to the Toulouse, France and Ann Arbor, US-based company with 15 years clinical and research experience, notably at Merck & Co and Bayer Healthcare Pharmaceuticals.

At Cerenis he will be responsible for the strategic planning and execution of the clinical trials for the company's portfolio of novel cardiovascular therapies, including lead product CER-001, which is currently being studied for acute coronary syndrome.

“The appointment of Dr Paolini comes at a crucial time in our development, with our lead drug candidate, CER-001 in phase II; this product addresses a significant unmet medical need and represents a multibillion dollar opportunity,” said Jean-Louis Dasseux, CEO of Cerenis.

29th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics